ClinicalTrialsFinder

Anal Squamous Cell Carcinoma, Limited-stage Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma, Limited-stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences350 enrolled2 locationsNCT07692152